baber/WOPTO huggingface dataset:
Patent NZ-512603-A (NZ)
Title: Method for producing a resealable pouch
Inventor: HOLLOWAY STEPHEN JOHN
IPC: B31B19/90
Filed: 2000-01-06
Abstract: A method of producing resealable filled pouches comprises the steps of (i) folding across part of its original width a length of thermoplastics sheet to produce a folded sheet having a fold portion running lengthways of the sheet having a folded edge which fold portion extends across part of the original width of the sheet and a non fold portion extending from the fold portion to the other edge of the sheet; (ii) in a direction at right angles to the folded edge and at regular intervals along the folded edge, welding the fold portion together to form individual pockets of equal size having welded wall edges along the length of the sheet; (iii) cutting the sheet, across the width of the sheet and along the line of the welds, to produce individual pouches each having a mouth, welded edges and an extended flap portion, and (iv) filling each pouch, through its mouth, with desired contents and folding the extended flap over the mouth so as to form the flap around the pouch. At the time of forming the fold portion of the sheet, a resealable fastener is located on the sheet in a direction parallel to the edges of the sheet and in a position predetermined to be immediately below the mouths of the pouches wherein the resealable fastener comprises two inter-engaging closure strips in engaged position, each closure strip of which having a base portion. The base portions of each of the two inter-engaging closure strips are, while the strips are engaged with each other, welded to the facing surfaces of the sheet respectively in the fold portion, and after welding of the resealable fastener the closure strips are disengaged from each other, the closure strips being made to engage with each other after the filling of the pouch and before forming the extended flap over the pouch.
Patent NZ-521015-A (NZ)
Title: Blood lancet with hygienic tip protection
Inventor: FRITZ MICHAEL
IPC: A61B17/34
Filed: 2001-02-28
Abstract: Lancet body (3) comprises elastic material into which the needle (1) tip (2) is embedded. Preferred features: In a development, the needle is movable within a hollow elastic body surrounding its tip region. The elastic body is penetrated when the needle is put to use, The tip is re-enclosed in the body, on withdrawal. The elastic material is a thermoplastic elastomer. It is stabled by a rigid material. In a set of such lancets, two are connected together by the elastic material. A lancet magazine is also claimed. This has independent chambers each with opening(s) for needle tip exit. The openings are closed by elastic material, which is penetrated by tip exit during use. each tip is sealed back into its chamber, on retraction.
Patent NZ-524617-A (NZ)
Title: Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production
Inventor: GAXIOLA ROBERTO A
IPC: C07K14/415
Filed: 2001-08-20
Abstract: Disclosed is a transgenic plant resistant to the effects of externally imposed stresses such as drought, freezing temperatures, high salt conditions, and the like. The transgenic plant contains a nucleotide sequence containing an exogenous tonoplast pyrophosphate driven H+ pump gene operationally linked to the to a regulatory element that results in altered expression of vacuolar pyrophosphatase. A transgenic plant is also provided for introducing into the genome of the plant an exogenous nucleic acid that alters the expression of vacuolar pyrophoshatase in the plant cell and one or more plant cells containing this exogenous nucleic acid wherein encodes AVP1. Also methods for increasing the production of seeds in plants by use of the pollen from the transgenic plant itself transformed with this phenotype to fertilize plants or the transgenic plant itself.
Patent NZ-527024-A (NZ)
Title: Method for decontamination of soil by fungal enzymes
Inventor: DUNCAN KELVIN WINSTON
IPC: B09C1/10
Filed: 2003-07-15
Abstract: A method for the treatment of soil to reduce the concentration of synthetic heterocyclic compound such as halogenated organic pesticides in the soil is disclosed, which comprises the steps of: (a) selection and preparation of a growth organism, wherein the selected organism secretes poly-aromatic hydrocarbon digesting enzymes, for example the growth organism may be a fungus such as Pleurotus; (b) selection and preparation of growth media; (c) formation of media mulch layer incorporating the growth media and the growth organism; (d) cultivation of the organism by application of the mulch layer over the soil; and (e) after a period of growth, mixing the mulch layer with the soil, enabling the secreted enzymes to contact the contaminants.
Patent NZ-534983-A (NZ)
Title: Vinyl ester adhesive compositions
Inventor: CHABUT BARBARA
IPC: C09J163/10
Filed: 2003-11-07
Abstract: A curable adhesive composition for anchoring materials in or to concrete or masonry, comprising: a. polymerizable vinyl ester corresponding to formula (II), wherein Ar is substituted or unsubstituted aromatic radical with a valence of at least two, R is independently a substituted or unsubstituted divalent radical derived from alkyl, oxyalkyl, arylalkyl, or oxyalkylaryl, R2 is independently H, substituted or unsubstituted vinyl carboxy radical, substituted or unsubstituted epoxy radical, or R, provided that the ratio of n to the number of vinyl carboxy R2 groups is, on average for the composition, from about 0.4 to about 2.0, for each Rx, x is independently 0 or 1, for each Oy, y is independently 0 or 1, for each (O-R2)z, z is independently 0 to 4, provided that at least one y must not be zero if z is zero, and n is from 1 to 5; b. an ethyleneically unsaturated monomer reactive with said polymerizable vinyl ester; c. curing catalyst; and d. activator, is disclosed. (62) Divided out of 529413
Patent NZ-535987-A (NZ)
Title: k-opioid receptor agonist comprising 2-henylbenzothiazoline derivative
Inventor: TOKAI MAKI
IPC: C07D417/12
Filed: 2003-03-28
Abstract: A kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative which is either a compound having a basic skeleton having a chemical structure represented by the general formula [I] or a salt of the compound. The presence of an amino-substituted alkyl group bonded to the phenyl group of 2-phenylbenzothiazoline and the presence of an acyl group bonded to the nitrogen atom of the 2-phenylbenzothiazoline are important for the impartation of kappa-opioid receptor agonistic activity.
Patent NZ-538169-A (NZ)
Title: Tag-based schema for distributing update metadata in an update distribution system
Inventor: AVERBUCH AARON H
IPC: G06F7/00
Filed: 2005-02-10
Abstract: A method for communicating update meta data corresponding to a software update from an update source computer using a tag-based structure is disclosed. The method comprises receiving an identifier element that uniquely identifies the software update. After the identifier element is received at least one of the following additional elements is then received: a properties element storing general property information relating the software update that includes update handler information identifying an update handler for installing the identified software update. a localized properties element for storing language specific information directed to a computer user relating to the software update; a relationship element storing relationships the software update has to other software updates available for installation on a computer; a file element identifying the identified software update's payload and information relating to the software update's payload and a handler element storing information for executing the update handler identified in the property elements for installing the identified software update. The at least one additional element describes aspects of the identified software update for determining the value and applicability of the identified software update such that communication resources may be preserved in not obtaining the identified software update's payload if the identified software update is of no value or inapplicable for installation on a computing system.
Patent NZ-540413-A (NZ)
Title: Fungicidal mixtures containing triazolopyrimidine derivatives and carbamates
Inventor: TORMO I BLASCO JORDI
IPC: A01N47/24
Filed: 2003-11-14
Abstract: Disclosed herein are fungicidal mixtures containing a triazolopyrimidine derivative of formula (I), and a carbamate of formula (II) wherein n represents 1 or 2, and X represents halogen, C1-C4alkyl or C1-C4haloalkyl, where the radicals X can differ from each other when n represents 2, in a synergistically effective amount. Methods for controlling pathogenic fungi using a combination of synergistically effective amounts of triazolopyrimidine compounds of formula (I) and carbamates of formula (II), and the use of said compounds (I) and (II) for producing such mixtures and compositions is also disclosed.
Patent NZ-541050-A (NZ)
Title: Human monoclonal antibodies against interleukin 8 (IL-8)
Inventor: BAADSGAARD OLE
IPC: C07K1/00
Filed: 2003-12-16
Abstract: Disclosed are isolated monoclonal antibodies which bind to human IL-8, wherein the antibodies have heavy and light chain sequences as defined in the specification.
Patent NZ-542909-A (NZ)
Inventor: GILCHRIST PETER M
IPC: H01R31/06
Filed: 2004-03-10
Abstract: An electrical adapter with a first pin configuration comprises a body for receiving and supporting a plug with a second pin configuration such that the pins of the plug are in electrical contact to the pins on the body, wherein the body is provided with a moveable member engageable by the plug and disposed to allow the plug to be inserted into the adapter but to restrict the retraction of the plug from the adapter.
Patent NZ-543212-A (NZ)
Title: Support device in a syringe pump for slidably bearing the free end of the lead screw in a tube
Inventor: BOYNE-AITKEN DAVID E
IPC: A61M5/145
Filed: 2004-04-28
Abstract: A lead screw mounting system for a syringe pump in which a second end of a lead screw is located within a hollow connection tube that connects a drive device engaged with the lead screw to a plunger drive head. A bearing mount is formed at the second end of the lead screw and a split bearing mounted to the bearing mount. The bearing mount has diverging bearing surfaces in an hour glass shape and the bearing has a complementary inner shape. The bearing is larger than the inner diameter of the connection tube and is in constant contact with the tube. During operation, the bearing tends to move up one or the other of the diverging bearing surfaces of the bearing mount depending on which direction the hollow connection tube is moving over the bearing creating a wedge action. The split bearing functions to keep the lead screw concentrically located within the hollow connection tube thereby increasing flow uniformity of the syringe pump.
Patent NZ-550343-A (NZ)
Title: External fixer for osteosynthesis
Inventor: STRUB BEAT
Filed: 2004-03-10
Abstract: The disclosure relates to an external fixer (1) for osteosynthesis, wherein a frame (2), which is provided with at least one bar (3a, 3b), absorbs the mechanical strain and can be joined to the bone by connecting means, wherein the connecting means are joined to the frame by means of clamping jaws (4). A module (5a), which can be placed on the frame, is also provided and is used to cause a relative movement of two bone fragments towards each other. The module comprises at least two components (6a,7a). The first component (6a) can be connected to the frame and the second component (7a) can be connected to at least one clamping jaw of a connecting means which is joined to a first bone fragment. The module also comprises a means (8a) enabling the second component to move in relation to the first component, such that the bone fragment, which is connected to the second component by means of the clamping jaw can be moved as a result of said relative movement.
Patent NZ-556762-A (NZ)
Title: Methods of fortifying process cheese with magnesium phosphate and products thereof
Inventor: BALDWIN CHERYL J
Filed: 2007-07-27
Abstract: Disclosed is method of making a nutritionally fortified process cheese product comprising combining, as a mixture, an emulsified cheese composition and magnesium phosphate in an amount effective for forming a magnesium-fortified process cheese product, wherein the magnesium phosphate is combined with the cheese composition in an amount effective to provide at least about 10 %DV of magnesium per serving of the process cheese product.
Patent NZ-565138-A (NZ)
Title: IL-1beta Binding antibodies and fragments thereof
Inventor: MASAT LINDA
IPC: A61P37/06
Filed: 2006-06-21
Abstract: An interleukin (IL)-1beta binding antibody comprising a heavy chain comprising SEQ ID NO: 28 and a light chain comprising SEQ ID NO: 27. The antibody binds to an epitope contained in the sequence SEQ ID NO: 36 and binds with a dissociation constant of 1 pM or less. The antibody can be used to treat an inflammatory disease, autoimmune disease or cancer.
Patent NZ-565498-A (NZ)
Title: Dispensing hinged closure made in one piece with a snap latch
Inventor: PUGNE DARIN M
IPC: B65D47/08
Filed: 2006-07-14
Abstract: A dispensing closure is disclosed. The closure includes a closure shell (30) of one-piece integrally moulded plastic construction that includes a base (32) for securing to a container neck finish and a lid coupled by a hinge to the base. The base has a deck and a skirt (44) as well as a deck recess (46) extending across the deck from a position adjacent to the hinge. A dispensing opening (66) in the deck recess (46) allows access to the contents of the container when the closure is open. A thumb recess in the skirt opens into the deck recess at a position opposite from the hinge. The lid is shaped for receipt in the deck recess in a closed position and a tongue (82) at an edge of the lid, remote from the hinge, has at least area (84) for frictional engagement with one rib (64) in the thumb recess. The lid has side edges (86, 88) that converge between the hinge and the tongue (82) and the deck recess has side edges complementary to the side edges of the lid.
Patent NZ-573490-A (NZ)
Title: An external power point arrangement
Inventor: NG WILSON
IPC: H01R24/76
Filed: 2008-12-10
Abstract: An electrical power fitting wall plate having a base 17.126 and a cover 17.122, the base 17.126 including a first cable slot 17.136, and the cover 17.122 having a second cable slot 17.130, whereby the base 17.126 and the cover 17.122 are adapted to receive a cable.
Patent NZ-575554-A (NZ)
Title: Manipulation of soluble carbohydrates (5) with fructan metabolism enzymes
Inventor: SPANGENBERG GERMAN
IPC: C12N15/84
Filed: 2001-10-10
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment from Lalium perenne or Lalium arundinaceum encoding a fructan metabolism enzyme or complementary or antisense to a sequence encoding a fructan metabolism enzyme. Further disclosed is a purified fructan metabolism enzyme. Also disclosed are vectors and plant cells containing said nucleic acid.
Patent NZ-576708-A (NZ)
Title: Method for selecting hop line and breeding marker and primer set used for selecting hop line
Inventor: OKADA YUKIO
IPC: C12N15/09
Filed: 2007-10-29
Abstract: Provided is a breeding marker which is used for screening of hop varieties with low ratio of cohumulone contents relative to acid contents in hops, comprising a specified nucleotide sequence and a specific single-nucleotide mutation. The markers can be used for screening of hop varieties.
Patent NZ-579780-A (NZ)
Title: Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes
Inventor: LIAO DER-ING
IPC: C12P7/16
Filed: 2008-04-16
Abstract: Disclosed is a method for conversion of acetolactate to dihydroxy-isovalerate comprising: a) providing a microbial host cell comprising a genetic construct encoding a polypeptide having ketol-acid reductoisomerase specific activity greater than that of the specific activity of an E. coli ketoI-acid reductoisomerase; and b) contacting the host cell of (a) with acetolactate wherein 2,3-dihydroxyisovalerate is produced, wherein the ketol-acid reductoisomerase enzyme has a specific activity of greater than 1.1 µmoles/min/mg based on purified protein as measured by the NADPH consumption assay, run under the following conditions: a) pH of about 7.5; b) a temperature of about 22.5°C; and c) greater than about 10mM potassium.
Patent NZ-581209-A (NZ)
Title: Port system for fastening a container with an internal hopper and tearable membrane to a connection system
Inventor: HENTZEL STEPHANE
IPC: B65D51/20
Filed: 2008-06-26
Abstract: Port System for Fastening a Container to a Connection System Port system for fastening a container with a vessel and an outlet to a connection system presenting an inlet. The port system includes a main skirt connectable to the outlet of the container presenting a connecting end and a discharge end. The port system has a hopper attached to the internal wall of the skirt. The hopper tapers to a discharge outlet in direction of the main skirt discharge end. The port system includes a tearable membrane which closes the skirt discharge end and the hopper.
Patent NZ-584519-A (NZ)
Title: Aryl amides useful as inhibitors of voltage-gated sodium channels
Inventor: CHEN WEICHUAN CAROLINE
IPC: C07D213/643
Filed: 2008-10-10
Abstract: The disclosure relates to aryl amide compounds of formula (I) which are useful as inhibitors of voltage-gated sodium channels, wherein the variables shown in formula (I) are as defined in the specification. The disclosure also relates to pharmaceutically acceptable compositions comprising these compounds and their use for treating or lessening the severity in a subject of one or more of acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epilepsy conditions, neurodegenerative disorders, psychiatric disorders such as anxiety and depression, dipolar disorder, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, cancer pain, stroke, cerebral ischemia, traumatic brain injury, amyotrophic lateral sclerosis, stress- or exercise induced angina, palpitations, hypertension, migraine, or abnormal gastro-intestinal motility.
Patent NZ-592159-A (NZ)
Title: Means and methods for influencing the stability of antibody producing cells
Inventor: SPITS HERGEN
IPC: C12N5/10
Filed: 2006-12-08
Abstract: Provided is an in vitro method for influencing the stability of an antibody producing cell, wherein the BCL6 expression is enhanced by expression of an exogenous BCL6 coding sequence and/or by providing the antigen producing cell with STAT5 directly or via expression of an exogenous STAT5 coding sequence and or culturing the antigen producing cell with IL-2 and/or IL-4; and increasing Bcl-xL expression by various means. The antigen producing cells can be stable for at least one week and as long as six months. Further provided are antibodies obtained by the method.
Patent NZ-595723-A (NZ)
Title: Amide derivative
Inventor: IKEDA TAKUYA
IPC: A61K31/42
Filed: 2010-03-15
Abstract: Disclosed is a compound of formula I, such as 1-{ 2-[{ 6-[({ 5-[{ 3-[({ [(2S)-1'-{ 2-[(5R)-3-[3,5- bis(trifluoromethyl)benzoyl]-5-(4-fluorophenyl)-1,3-oxazolidin-5-yl]ethyl} -2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl]oxy} acetyl)(methyl)amino]propyl} (methyl)carbamoyl]-2-thienyl} methyl)amino]hexanoyl} (methyl)amino]ethyl} piperidin-4-yl biphenyl-2-ylcarbamate and 1-(2-{ [6-({ 6-[{ 3-[({ [(2S)-1'-{ 2-[(5R)-3-[3,5-bis(trifluoromethyl)benzoyl]-5-(4-fluorophenyl)-1,3-oxazolidin-5-yl]ethyl} -2,3-dihydrospiro[indene-1,4'-piperidin]-2-yl]oxy} acetyl)(methyl)amino]propyl} (methyl)carbamoyl]pyridin-3-yl} amino)hexanoyl](methyl)amino} ethyl)piperidin-4-yl biphenyl-2-ylcarbamate, which is useful for treating diseases or disorders mediated by a neurokinin NK1 receptor, NK2 receptor and a muscarine M3 receptor such as respiratory, allergic and neurological diseases.
Patent NZ-596701-A (NZ)
Title: Mechanism for setting a dose on a drug delivery device comprising a shaft with a helical thread engaged with a nut member, wherein the helical thread comprises a first, second and third pitch
Inventor: PLUMPTRE DAVID
IPC: A61M5/315
Filed: 2010-05-28
Abstract: 596701 A dose setting mechanism for a drug delivery device, such as a pen type drug delivery device, with a cartridge of medication, wherein the dose setting mechanism is operable to select a dose of medication which shall be administered out of said cartridge is disclosed. The dose setting mechanism comprises a shaft (30), a helical groove (32), and a nut member. The nut member is disposed on the helical groove of the shaft. The helical groove has a first pitch provided along a first portion (34) of the shaft, a second pitch provided along a second portion (36) of the shaft, and a third pitch provided along a third portion (35) of the shaft, wherein the second portion is provided at the end of the first portion and the third portion is provided at the end of the second portion. The second pitch is greater than the first pitch and the first pitch is generally equal to the third pitch. The second pitch acts as a means for preventing a user of the dose setting mechanism from setting a dose of the medication that is greater than any remaining medication in the cartridge. During dose setting of the drug delivery device, the shaft is rotated relative to the nut member while the nut member traverses in longitudinal direction along the helical groove from a first end of the shaft towards a second end of the shaft.
Patent NZ-600325-A (NZ)
Title: Determining methane content of a bottom sample
Inventor: KLOMP ULFERT CORNELIS
IPC: G01N1/40
Filed: 2010-11-15
Abstract: A methane content of a bottom sample comprising methane hydrate crystals is determined by: - taking a core sample from a bottom sediment in a deep water area; - storing the core sample in a storage chamber; - lifting the storage chamber to a predetermined water depth at which any methane hydrate crystals in the core sample dissociate into water and methane; and - measuring an amount of methane released by the lifted core sample.
Patent NZ-600528-A (NZ)
Title: Therapeutic use of protein-polymer conjugates
Inventor: LIN KO-CHUNG
IPC: A61P31/00
Filed: 2010-12-09
Abstract: Patent No. 600528 Disclosed is the use of an effective amount of a substantially pure conjugate having at least one polymer moiety, a protein moiety, and a linker, wherein the at least one polymer moiety is attached to the linker, the nitrogen atom of the N-terminus of the protein moiety is bonded to the linker, the linker is a covalent bond, C1-10 alkylene, C2-10 alkenylene, or C2-10 alkynylene, and the protein moiety is an interferon-alpha moiety, in the manufacture of a medicament for the treatment of idiopathic myelofibrosis, polycythaemia vera, or essential thromobocythaemia.